Binder profile
ZINC1857792272
Virtual-screening candidate from ZINC.
Bound to: PA5514 — beta-lactamase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC1857792272- UniProt (similar protein)
Q9L4P2- Tanimoto
- 0.615
- Target protein
- PA5514
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- MW ≤ 500 Da 324.1
- LogP ≤ 5 0.86
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 91.3
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COCC(=O)OCOC(=O)c1c(F)ccc2c1OB(O)[C@@H]1C[C@H]21COCC(=O)OCOC(=O)c1c(F)ccc2c1OB(O)[C@@H]1C[C@H]21
InChI=1S/C14H14BFO7/c1-20-5-11(17)21-6-22-14(18)12-10(16)3-2-7-8-4-9(8)15(19)23-13(7)12/h2-3,8-9,19H,4-6H2,1H3/t8-,9-/m1/s1InChI=1S/C14H14BFO7/c1-20-5-11(17)21-6-22-14(18)12-10(16)3-2-7-8-4-9(8)15(19)23-13(7)12/h2-3,8-9,19H,4-6H2,1H3/t8-,9-/m1/s1
MOEDEYVUTCDHEC-RKDXNWHRSA-NMOEDEYVUTCDHEC-RKDXNWHRSA-N
Provenance
Annotation context from LigQ_2, the internal TPW step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- RM9
- Homolog
- Q9L4P2
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC1857792272 →
- ZINC ZINC20 ZINC1857792272 →
- UniProt UniProt Q9L4P2 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC1857792272”) →
Other binders for this protein
Quick navigation to other ligands bound to PA5514.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 2
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 48
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).